OTC · SCPS
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Sep 18, 2026, 5:07 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 6 trading sessions · Daily adjusted prices
SCPS closed at $0.00 after 6 trading sessions, up 50.00% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 5K |
| Sep 11, 2026 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 2.82K |
| Sep 10, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 500 |
| Aug 27, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 1.2K |
| Aug 25, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 200 |
| Aug 20, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 489 |
The latest Smart Investors Daily articles mentioning SCPS.
SCPS research
Company profile and research snapshot.
SCOPUS BIOPHARMA INC
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 16, 2021 | Benchmark | Speculative Buy | — |
No generated briefing is available yet.
defenseworld.net · Dec 10, 2025
Institutional and Insider Ownership 18.4% of MorphoSys shares are held by institutional investors. 0.1% of MorphoSys shares are held by insiders. Comparatively, 5.1% of Scopus BioPharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SCPS.
No results
No recent SID articles mention SCPS.
